Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
暂无分享,去创建一个
Daniel Metzger | T. Kitamoto | S. Masushige | E. Nishida | Y. Gotoh | D. Metzger | S. Kato | H. Endoh | Y. Masuhiro | Shimami Uchiyama | H. Sasaki | H. Kawashima | P. Chambon | Shigeaki Kato | Yukiko Gotoh | Eisuke Nishida | Takuya Kitamoto | Pierre Chambon | Hideki Endoh | Yoshikazu Masuhiro | Shimami Uchiyama | Haruna Sasaki | Shoichi Masushige | Hiroyuki Kawashima
[1] C. Marshall,et al. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.
[2] B. O’Malley,et al. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.
[3] S. Fawell,et al. Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor. , 1989, Journal of steroid biochemistry.
[4] E. Nishida,et al. Involvement of the MAP kinase cascade in Xenopus mesoderm induction. , 1995, The EMBO journal.
[5] Gene regulation by steroid hormones , 1989, Cell.
[6] P. Chambon,et al. A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5′-TGACC-3′ motifs acting synergistically , 1992, Cell.
[7] R. Clarke,et al. MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780. , 1993, Cancer research.
[8] N. Webster,et al. The human estrogen receptor has two independent nonacidic transcriptional activation functions , 1989, Cell.
[9] P. Chambon,et al. Nuclear receptors enhance our understanding of transcription regulation. , 1988, Trends in genetics : TIG.
[10] S. Pelech,et al. MAP kinases: charting the regulatory pathways. , 1992, Science.
[11] W. Gullick. Growth factors and oncogenes in breast cancer. , 1990, Progress in growth factor research.
[12] W. Gullick,et al. Type 1 growth factor receptors: an overview of recent developments , 1995 .
[13] Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. , 1993, Molecular endocrinology.
[14] S. F. Arnold,et al. In vivo and in vitro phosphorylation of the human estrogen receptor , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[15] G. McKnight,et al. Regulation of transcription by cyclic AMP-dependent protein kinase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[16] K. Korach,et al. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. , 1993, Molecular endocrinology.
[17] P. Chambon,et al. Characterization of the Amino-terminal Transcriptional Activation Function of the Human Estrogen Receptor in Animal and Yeast Cells (*) , 1995, The Journal of Biological Chemistry.
[18] E. Nishida,et al. In vitro effects on microtubule dynamics of purified Xenopus M phase-activated MAP kinase , 1991, Nature.
[19] E. Nishida,et al. Characterization of recombinant Xenopus MAP kinase kinases mutated at potential phosphorylation sites. , 1994, Oncogene.
[20] P. Chambon,et al. Role of the two activating domains of the oestrogen receptor in the cell‐type and promoter‐context dependent agonistic activity of the anti‐oestrogen 4‐hydroxytamoxifen. , 1990, The EMBO journal.
[21] C. Benz,et al. Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer. , 1989, Cancer research.
[22] H. Gronemeyer,et al. Transcription activation by estrogen and progesterone receptors. , 1991, Annual review of genetics.
[23] P. Chambon,et al. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. , 1995, Molecular endocrinology.
[24] V. Jordan,et al. Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. , 1988, Cancer research.
[25] K. Korach,et al. Uterine estrogen receptor in vivo: phosphorylation of nuclear specific forms on serine residues. , 1991, Molecular endocrinology.
[26] R. Davis,et al. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. , 1991, The Journal of biological chemistry.
[27] P. Chambon,et al. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function , 1988, Cell.
[28] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[29] N. Koszewski,et al. Estrogen receptor phosphorylation. Hormonal dependence and consequence on specific DNA binding. , 1992, The Journal of biological chemistry.
[30] P. Chambon,et al. Functional domains of the human estrogen receptor , 1987, Cell.
[31] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[32] J. Lees,et al. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.
[33] K. Kaibuchi,et al. Transforming and c-fos promoter/enhancer-stimulating activities of a stimulatory GDP/GTP exchange protein for small GTP-binding proteins. , 1992, The Journal of biological chemistry.
[34] Richard Treisman,et al. Transcriptional Regulation by Extracellular signals: Mechanisms and Specificity , 1995, Cell.
[35] A. deFazio,et al. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. , 1994, Oncogene.
[36] B. Katzenellenbogen,et al. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. , 1994, The Journal of biological chemistry.
[37] L. Murphy,et al. Epidermal growth factor: receptor and ligand expression in human breast cancer. , 1990, Seminars in cancer biology.
[38] D. Lannigan,et al. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. , 1995, Molecular endocrinology.
[39] P. Chambon,et al. Modulation of transcriptional activation by ligand‐dependent phosphorylation of the human oestrogen receptor A/B region. , 1993, The EMBO journal.